IRIS PubliCatt

Schinzari, Giovanni
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 1.926
EU - Europa 1.755
AS - Asia 659
AF - Africa 38
OC - Oceania 12
SA - Sud America 6
Continente sconosciuto - Info sul continente non disponibili 4
Totale 4.400
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.906
SE - Svezia 467
DE - Germania 450
IT - Italia 284
SG - Singapore 237
CN - Cina 223
IE - Irlanda 114
FR - Francia 91
ID - Indonesia 72
UA - Ucraina 68
GB - Regno Unito 64
IN - India 55
PL - Polonia 53
FI - Finlandia 42
RU - Federazione Russa 41
CI - Costa d'Avorio 38
TR - Turchia 27
BE - Belgio 21
CA - Canada 17
IR - Iran 16
CZ - Repubblica Ceca 12
RO - Romania 12
AU - Australia 11
HK - Hong Kong 9
NL - Olanda 7
JP - Giappone 6
AT - Austria 5
ES - Italia 5
CH - Svizzera 4
PE - Perù 4
EU - Europa 3
GR - Grecia 3
KR - Corea 3
LT - Lituania 3
NO - Norvegia 3
CY - Cipro 2
HR - Croazia 2
IL - Israele 2
MX - Messico 2
PK - Pakistan 2
VN - Vietnam 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AE - Emirati Arabi Uniti 1
BG - Bulgaria 1
BN - Brunei Darussalam 1
CL - Cile 1
CO - Colombia 1
CR - Costa Rica 1
IS - Islanda 1
LA - Repubblica Popolare Democratica del Laos 1
LV - Lettonia 1
NZ - Nuova Zelanda 1
RS - Serbia 1
Totale 4.400
Salva come PNG Salva come JPEG
Città #
Chandler 481
Singapore 185
Ashburn 145
Dublin 114
New York 85
Jakarta 72
Wilmington 66
San Mateo 63
Fairfield 56
Ann Arbor 55
Warsaw 52
Princeton 46
Rome 46
Nanjing 44
Jacksonville 42
Marseille 39
Abidjan 38
Boston 38
Milan 37
Dearborn 35
Cattolica 33
Moscow 31
Beijing 27
Los Angeles 27
Redwood City 26
Seattle 26
Nürnberg 25
Woodbridge 25
Cambridge 24
Redmond 24
Helsinki 23
Brussels 21
Bremen 20
Houston 20
Izmir 17
Munich 17
Nanchang 17
Boardman 16
Falls Church 14
London 14
Shanghai 14
Hebei 12
Augusta 11
Chicago 11
Norwalk 11
Lawrence 10
Leawood 10
Changsha 8
Paris 8
Washington 8
Brno 7
Frankfurt am Main 7
Hong Kong 7
Kish 7
Mountain View 7
Ottawa 7
Falkenstein 6
Guangzhou 6
Jiaxing 6
Kunming 6
Santa Clara 6
Shenyang 6
Andover 5
Bari 5
Edinburgh 5
Fremont 5
Miami 5
Pune 5
San Diego 5
Amsterdam 4
Hangzhou 4
Hefei 4
Lappeenranta 4
Lima 4
Mumbai 4
Sant'Elpidio a Mare 4
Sydney 4
Tokyo 4
Toronto 4
University Park 4
Vienna 4
Winston Salem 4
Ardea 3
Berlin 3
Ciserano 3
Detroit 3
Florence 3
Gunzenhausen 3
Hounslow 3
Kashan 3
Lanzhou 3
Lanzo d'Intelvi 3
Northbrook 3
Nuremberg 3
Prague 3
Somma Vesuviana 3
Tianjin 3
Turin 3
Verbania 3
Acquaviva delle Fonti 2
Totale 2.507
Salva come PNG Salva come JPEG
Nome #
Pembrolizumab as first-line treatment for metastatic uveal melanoma 270
KRAS mutational status affects oxaliplatin-based chemotherapy independently from basal mRNA ERCC-1 expression in metastatic colorectal cancer patients 183
Nevirapine restores androgen signaling in hormone-refractory human prostate carcinoma cells both in vitro and in vivo 128
Neoadjuvant treatment of unresectable liver disease with irinotecan and 5-fluorouracil plus folinic acid in colorectal cancer patients 128
Final analysis of colorectal cancer patients treated with irinotecan and 5-fluorouracil plus folinic acid neoadjuvant chemotherapy for unresectable liver metastases 126
7-Year survival results of perioperative chemotherapy with epidoxorubicin, etoposide, and cisplatin (EEP) in locally advanced resectable gastric cancer: up-to-date analysis of a phase-II study 110
KRAS Exon 2 Mutations as Prognostic Indicators in Advanced Colorectal Cancer in Clinical Practice: A Mono-Institutional Study 108
Are TKIs favourable for the elderly with non-small-cell lung cancer? 107
Polymorphism of CAG motif of SK3 gene is associated with acute oxaliplatin neurotoxicity 104
Gastrointestinal stromal tumors (GISTs) and second malignancies A novel sentinel tumor? A monoinstitutional, STROBE-compliant observational analysis 100
Management of the kidney transplant patient with Cancer: Report from a Multidisciplinary Consensus Conference 88
ERCC1 expression affects outcome in metastatic pancreatic carcinoma treated with FOLFIRINOX: A single institution analysis. 84
From 2000 to 2016: Which Second-Line Treatment in Advanced Non-Small Cell Lung Cancer? 83
Targeted Therapy in Advanced Gastric Carcinoma:the Future is Beginning 78
Hyperthermic intrathoracic chemotherapy combined to iterative cytoreductive surgery to treat a pleural carcinosis from psudomixoma peritonei. A case report 78
Contact skin radiotherapy (brachytherapy) for the treatment of non-melanoma skin cancers during COVID-19 pandemic 78
IL-8 and eNOS polymorphisms predict bevacizumab-based first line treatment outcomes in RAS mutant metastatic colorectal cancer patients 77
Cardiac metastasis from renal cell carcinoma successfully treated with pazopanib: impact of TKIs' antiangiogenic activity. 74
RUNX3 as a Potential Predictor of Metastasis in Human Pancreatic Cancer 73
Risk factors for pancreas and lung neuroendocrine neoplasms: a case–control study 73
Gene expression profiling of pancreas neuroendocrine tumors with different ki67‐based grades 69
TK Inhibitor Pazopanib Primes DCs by Downregulation of the β-Catenin Pathway 68
Maintenance hormonal and chemotherapy treatment in metastatic breast cancer: a systematic review. 67
Dabrafenib and Trametinib in BRAF Mutant Metastatic Conjunctival Melanoma 66
Management of the kidney transplant patient with Cancer: Report from a Multidisciplinary Consensus Conference 64
Immune-checkpoint inhibitors in renal transplanted patients affected by melanoma: A systematic review 64
Immunological backbone of uveal melanoma: Is there a rationale for immunotherapy? 63
Cisplatin, dacarbazine and vinblastine as first line chemotherapy for liver metastatic uveal melanoma in the era of immunotherapy: A single institution phase II study 61
First-line treatment of advanced biliary ducts carcinoma: A randomized phase II study evaluating 5-FU/LV Plus oxaliplatin (Folfox 4) versus 5-FU/LV (de gramont regimen) 61
Pancreatic neuroendocrine tumors in MEN1 disease: a mono-centric longitudinal and prognostic study 59
The risk of malignancy of atypical urothelial cells of undetermined significance in patients treated with chemohyperthermia or electromotive drug administration 58
The Interplay between Immunity and Microbiota at Intestinal Immunological Niche: The Case of Cancer 58
Long term follow up of a pilot study with neoadjuvant EEP ( epidoxorubicin, Etoposide and Cisplatin) in gastric cancer. 58
Immunotherapy and radiotherapy in melanoma: a multidisciplinary comprehensive review 58
Multidisciplinary ocular and periocular cancers meetings: implementation in a tertiary referral center and analysis over a 12-months period 57
Skin cancer triage and management during COVID-19 pandemic. 57
Monoinstitutional real world experience in management of vinflunine as second line therapy for transitional cell carcinoma of the urothelium 55
Methylation study of the Paris system for reporting urinary (TPS) categories 55
Faecal microbiota transplantation for the treatment of diarrhoea induced by tyrosine-kinase inhibitors in patients with metastatic renal cell carcinoma 55
Prognostic factors affecting survival after pulmonary resection of metastatic renal cell carcinoma: A multicenter experience 55
Conjunctival melanoma: Genetic and epigenetic insights of a distinct type of melanoma 54
Going towards a precise definition of the therapeutic management of de-novo metastatic castration sensitive prostate cancer patients: How prognostic classification impact treatment decisions 53
Biomarkers of response to advanced prostate cancer therapy 52
Neoadjuvant chemotherapy for patients with muscle-invasive urothelial bladder cancer candidates for curative surgery: A prospective clinical trial based on cisplatin feasibility 51
Proteomics of Pancreatic Neuroendocrine Tumors: A Systematic Review 51
Efficacy of immune checkpoint inhibitors in different types of melanoma 50
INfluenza Vaccine Indication During therapy with Immune checkpoint inhibitors: a transversal challenge. The INVIDIa study. 49
Are Markers of Systemic Inflammation Good Prognostic Indicators in Colorectal Cancer? 49
Successful "on- demand" plerixafor for autologous peripheral blood stem-cells transplantation for relapsed/refractory germ cell tumors. 49
First Case of Mature Teratoma and Yolk Sac Testis Tumor Associated to Inherited MEN-1 Syndrome. 48
Hepatic Radiotherapy in Addition to Anti-PD-1 for the Treatment of Metastatic Uveal Melanoma Patients 45
Long-term follow-up of a pilot phase II study with neoadjuvant epidoxorubicin, etoposide and cisplatin in gastric cancer 45
The role of postoperative radiotherapy in eccrine porocarcinoma: a multidisciplinary systematic review 42
Unconventional radiotherapy to enhance immunotherapy efficacy in bulky tumors: a case report 38
“Skin rashes” and immunotherapy in melanoma: distinct dermatologic adverse events and implications for therapeutic management 37
Dabrafenib-Trametinib and Radiotherapy for Oligoprogressive BRAF Mutant Advanced Melanoma 33
Pituitary Enlargement and Hypopituitarism in Patients Treated with Immune Checkpoint Inhibitors: Two Sides of the Same Coin? 33
Reduced expression and altered subcellular localization of the cyclin-dependent kinase inhibitor p27(Kip1) in human colon cancer. 32
Competitive testing of the WHO 2010 versus the WHO 2017 grading of pancreatic neuroendocrine neoplasms: Data from a large international cohort study 31
Radiomics to predict immunotherapy efficacy in advanced renal cell carcinoma: A retrospective study 28
Direct effects of GnRH agonists in human hormone-sensitive endometrial cells 28
Circulating immune profile can predict survival of metastatic uveal melanoma patients: results of an exploratory study 27
Surgical Resection of Pulmonary Metastases from Melanoma in Oligometastatic Patients: Results from a Multicentric Study in the Era of Immunoncology and Targeted Therapy 25
Targeted therapy in advanced gastric carcinoma: The future is beginning 25
Safety and efficacy of endoscopic ultrasound-guided radiofrequency ablation for pancreatic insulinoma: A single-center experience 23
Pancreas as an Unusual Metastatic Site of Medullary Thyroid Carcinoma: A Case of Very Long-term Follow-up Under Prolonged Treatment with Somatostatin Analogues 23
The role of stereotactic radiotherapy in addition to immunotherapy in the management of melanoma brain metastases: results of a systematic review 21
Secukinumab in Patients with Psoriasis and a Personal History of Malignancy: A Multicenter Real-Life Observational Study 18
No evidence of association between psychological distress and pain relief in patients with bone metastases from castration-resistant prostate cancer treated with 223Radium 17
The Role of Postoperative Radiotherapy in the Management of Dermatofibrosarcoma Protuberans: A Multidisciplinary Systematic Review 17
Safety and efficacy of endoscopic ultrasound-guided radiofrequency ablation for pancreatic insulinoma: A single-center experience 13
Pneumonitis from immune checkpoint inhibitors and COVID-19: current concern in cancer treatment 12
Aggressive PitNETs and Potential Target Therapies: A Systematic Review of Molecular and Genetic Pathways 11
Is 18F-fluorodeoxyglucose the tracer of choice for functional imaging of neuroendocrine tumors grade 3? A case report 8
Atypical Presentation of Splenic Tissue Mimicking Neuroendocrine Tumor Relapse 5
Totale 4.501
Salva come PNG Salva come JPEG
Categoria #
all - tutte 23.711
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 23.711
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020298 0 0 0 0 42 35 73 13 24 22 70 19
2020/2021246 10 19 8 15 30 9 33 9 31 28 50 4
2021/2022636 59 18 15 99 39 14 13 86 33 43 95 122
2022/20231.381 181 178 100 226 57 158 103 121 143 32 59 23
2023/2024762 35 169 47 41 31 111 52 33 14 34 106 89
2024/2025421 35 54 124 70 138 0 0 0 0 0 0 0
Totale 4.501